Skip to main content
. Author manuscript; available in PMC: 2020 Jan 1.
Published in final edited form as: Mucosal Immunol. 2019 May 3;12(4):874–887. doi: 10.1038/s41385-019-0165-1

Fig. 4.

Fig. 4

BMMs and intestinal myeloid cells from IRF5−/− mice are less effective at clearance of intracellular bacteria and production of bacterial-induced inflammatory cytokines in vitro. a, b BMMs from IRF5+/+, IRF5+/− or IRF5−/− mice were: (a) left untreated or treated for 48 h with 0.1 μg/ml lipid A and then co-cultured with S. Typhimurium, AIEC or S. aureus as per Methods for ‘Intracellular bacterial clearance’. Bacterial CFU (4 replicates, representative of 3 independent experiments). b Co-cultured with S. Typhimurium, AIEC or S. aureus and supernatants were assessed for cytokines 24 h later (4 replicates). Significance for A & B is compared to IRF5+/+ macrophages for each respective treatment condition or as indicated. c, d Colonic lamina propria macrophages were co-cultured with S. Typhimurium and gentamicin was added 20 min later. c Bacterial CFU (6 replicates) assessed at the indicated times after gentamicin. d Cytokines (4 replicates) at 20 h. Mean + SEM. *p < 0.05; **p < 0.01; ***p < 0.001; p < 1 × 10−4; ††p < 1 × 10−5